Animal facility - Mouse cancer clinic

The MCCA preclinical intervention facility uses advanced mouse models as surrogate for cancer patients, to identify and validate targets that can be exploited by anti-cancer therapy. The main objective is to find and test novel anti-cancer treatments. Our cancer models include transgenic (spontaneous) mouse models, orthotopic transplantation models and human xenograft models developed/established at the NKI.

We also have state-of-the-art small animal imaging systems as well as an image-guided radiation therapy system to deliver local and precise radiation beams. 

The Pharmacology unit, with which we collaborate, performs preclinical pharmacology-pharmacokinetics studies to study if a compound reaches its target in pharmacologically meaningful quantities. The treatment and longitudinal follow-up of tumors is facilitated by a fully trained and dedicated team of technicians who perform surgeries and caliper measurements.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.